3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor
Conditions
Leukemia, Myeloid, Acute
17
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Lymphoma, Non-Hodgkin
12
Myelodysplastic Syndromes
11
Recurrence
7
Leukemia, Myelomonocytic, Chronic
7
Anemia, Refractory, with Excess of Blasts
7
Leukemia, Biphenotypic, Acute
6
Multiple Myeloma
5
Lymphoma, Follicular
5
Lymphoma
5
Hodgkin Disease
5
Hematologic Neoplasms
5
Melanoma
4
Lymphoma, Large B-Cell, Diffuse
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Burkitt Lymphoma
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Myeloproliferative Disorders
3
Lymphoma, Mantle-Cell
3
Lymphoma, B-Cell, Marginal Zone
3
Lymphoma, B-Cell
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia
3
Breast Neoplasms
3
Blastic Plasmacytoid Dendritic Cell Neoplasm
3
Uveal Melanoma
2
Triple Negative Breast Neoplasms
2
Neoplasms, Plasma Cell
2
Neoplasms, Germ Cell and Embryonal
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recruiting
×
Neoplasms, Squamous Cell
×
fludarabine phosphate
×
Clear all
No trials found.